US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroBo Pharmaceuticals, Inc.

2.36

+0.0000

Volume:- -

Turnover:31.15K

Market Cap:20.33M

PE:-0.55

High:2.36

Open:2.36

Low:2.36

Close:2.36

Loading ...

Overview Company News Filings

BUZZ-NeuroBo Pharma rises as obesity drug meets main goal in early-stage study

NeuroBo Pharmaceuticals Shares up 4.2% Premarket After Positive Results From Early-Stage Study for Obesity Drug

THOMSON REUTERS

NeuroBo Pharmaceuticals Inc - Data Shows Favorable Safety, Tolerability, and Dose-Linear Pk

THOMSON REUTERS

NeuroBo Pharmaceuticals Inc - Top-Line Data From Mad Part 2 Expected Q1 2025

THOMSON REUTERS

NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity

THOMSON REUTERS

NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

NRBO: Data from Part 1 of Phase 1 Trial of DA-1726 in 3Q24…

Zacks Small Cap Research

NeuroBo Pharmaceuticals Shares Rise After Reporting Q2 Results

MT Newswires Live

NeuroBo Pharmaceuticals Shares Rise After Reporting Q2 Results

MT Newswires Live

NeuroBo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

NeuroBo Pharmaceuticals Q2 EPS $(1.85) Misses $(1.12) Estimate

NeuroBo Pharmaceuticals: Part 2 of Phase 2a Trial of Da-1241 for Treatment of Mash Underway With Top-Line Data Expected in Q4 of 2024

THOMSON REUTERS

NeuroBo Pharmaceuticals: Joint Research Agreement With Dong-a St & Immunoforge to Develop Long-Acting Once-Monthly Formulation of Da-1726

THOMSON REUTERS

NeuroBo Pharmaceuticals: Cash at End of Q2 Expected to Fund Co Into Q2 of 2025

THOMSON REUTERS

NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update

NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial

BRIEF-Neurobo Pharmaceuticals Completes Enrollment Of The Sad Part 1 Of Its Phase 1 Clinical Trial Evaluating Da-1726

NeuroBo Pharmaceuticals Completes Enrollment of the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity

THOMSON REUTERS

NeuroBo Pharmaceuticals Inc - Top Line Data From Sad Part 1 Expected Q3 2024

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRBO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRBO\",,,,,undefined,":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":2.36,"timestamp":1732741200000,"preClose":2.36,"halted":8,"volume":0,"delay":0,"floatShares":2196834,"shares":8616010,"eps":-4.294645,"marketStatus":"Market Closed","change":0,"latestTime":"11-27 16:00:00 EST","open":2.36,"high":2.36,"low":2.36,"amount":31147.715098499997,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.294645,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"MTVA","executeDate":"2024-11-29"},"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":2.36,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRBO\",,,,,undefined,":{"symbol":"NRBO","floatShares":2196834,"roa":"-74.35%","roe":"-160.76%","lyrEps":-2.459032,"shares":8616010,"dividePrice":0,"high":2.36,"amplitude":0,"preClose":2.36,"low":2.36,"week52Low":2.08,"pbRate":"1.57","week52High":6.7499,"institutionHeld":0,"latestPrice":2.36,"eps":-4.294645,"divideRate":0,"volume":0,"delay":0,"ttmEps":-4.294645,"open":2.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRBO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2471480257","title":"BUZZ-NeuroBo Pharma rises as obesity drug meets main goal in early-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2471480257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471480257?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:34","pubTimestamp":1727699696,"startTime":"0","endTime":"0","summary":"** Shares of drug developer NeuroBo Pharmaceuticals    rise 3.3% to $3.43 premarket    ** Co says its obesity drug was found to be safe and well tolerated and did not result in any serious adverse effects in an early-stage study conducted with 45 obese, otherwise healthy individuals   ** The main goal of the study was to assess the safety and tolerability of the drug by monitoring adverse events   ** Five subjects receiving the treatment reported adverse events vs 3 subjects in the placebo group - NRBO says   ** As of last close, stock down 10.2% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2471804080","title":"NeuroBo Pharmaceuticals Shares up 4.2% Premarket After Positive Results From Early-Stage Study for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2471804080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471804080?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:28","pubTimestamp":1727699290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nFWN3LC0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2471801372","title":"NeuroBo Pharmaceuticals Inc - Data Shows Favorable Safety, Tolerability, and Dose-Linear Pk","url":"https://stock-news.laohu8.com/highlight/detail?id=2471801372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471801372?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:01","pubTimestamp":1727697663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA9DYDDY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2471801308","title":"NeuroBo Pharmaceuticals Inc - Top-Line Data From Mad Part 2 Expected Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2471801308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471801308?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:01","pubTimestamp":1727697663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA9DYDDY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2471377801","title":"NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2471377801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471377801?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:01","pubTimestamp":1727697663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA9DYDDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2471225804","title":"NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2471225804","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471225804?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:01","pubTimestamp":1727697660,"startTime":"0","endTime":"0","summary":"Top-Line Data Readout from the MAD Part 2 Expected in the First Quarter of 2025. Planned Phase 1 Part 3 Will Evaluate Early Proof of Concept. CAMBRIDGE, Mass., Sept. 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive top-line safety, tolerability, and dose-linear pharmacokinetics  data from the single ascending dose  Part 1 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin  analog agonist that functions as a glucagon-like peptide-1 receptor  and glucagon receptor , for the treatment of obesity.The primary endpoint of the Phase 1 trial is to assess the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wllL3EUGQ36ieARbwNjVMw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/396f0291274a12c8d755e897f554a350","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wllL3EUGQ36ieARbwNjVMw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/396f0291274a12c8d755e897f554a350"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-positive-top-120100652.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-positive-top-120100652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OXM","BK4218","BK4139","NRBO","BK4157","BMI","PK","BK4181","BK4202"],"gpt_icon":0},{"id":"2461746138","title":"NRBO: Data from Part 1 of Phase 1 Trial of DA-1726 in 3Q24…","url":"https://stock-news.laohu8.com/highlight/detail?id=2461746138","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461746138?lang=en_us&edition=fundamental","pubTime":"2024-08-21 21:34","pubTimestamp":1724247240,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals, Inc.  is currently conducting a Phase 1 clinical trial of DA-1726 for the treatment of obesity. DA-1726 is a novel oxyntomodulin  analogue that functions as a dual agonist of the GLP-1 receptor  and the glucagon receptor . Part 1 of the trial is a single ascending dose  study that enrolled 45 obese but otherwise healthy participants randomized into one of five planned cohorts in a 6:3 ratio of DA-1726 or placebo. Part 2 of the trial is a multiple ascending dose  study that is expected to enroll approximately 36 obese but otherwise healthy participants into four planned cohorts, with each to receive four weekly administrations of DA-1726 or placebo, randomized in a 6:3 ratio. The primary endpoint will assess the safety and tolerability of DA-1726 with secondary endpoints examining the pharmacokinetics  of DA-1726. Exploratory endpoints include the effect of DA-1726 on metabolic parameters, cardiac parameters, fasting lipid levels, body weight, waist circumferenc","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nqtpGf6oLJsh.6odwOPXaw--~B/aD05ODg7dz0xNjQ0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/84f84c08241b52eca14ca7f03e2f6fb1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nqtpGf6oLJsh.6odwOPXaw--~B/aD05ODg7dz0xNjQ0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/84f84c08241b52eca14ca7f03e2f6fb1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrbo-data-part-1-phase-133400671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","BK4139","BK4081","OXM","BK4218","NRBO","BK4181","PK","ELP"],"gpt_icon":0},{"id":"2459979486","title":"NeuroBo Pharmaceuticals Shares Rise After Reporting Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2459979486","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459979486?lang=en_us&edition=fundamental","pubTime":"2024-08-15 02:25","pubTimestamp":1723659936,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4505","BK4531","BK4552","IQ","BK4526","BK4139","BK4108","NRBO"],"gpt_icon":0},{"id":"2459617486","title":"NeuroBo Pharmaceuticals Shares Rise After Reporting Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2459617486","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459617486?lang=en_us&edition=fundamental","pubTime":"2024-08-15 02:25","pubTimestamp":1723659936,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals  shares were up nearly 8% in recent trading Wednesday after the company reported its Q2 results.The company reported Q2 net loss of $1.85 per diluted share, widening from a loss of $0.15 a year earlier.Three analysts surveyed by Capital IQ expected a loss of $1.12The company did not report revenue for the quarter ended June 30.NeuroBo Pharmaceuticals said it had $27.9 million in cash as of June 30 and expects its cash position to fund the company's operations into Q2 2025.Price: 4.01, Change: +0.29, Percent Change: +7.80","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2459170656","title":"NeuroBo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2459170656","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459170656?lang=en_us&edition=fundamental","pubTime":"2024-08-14 22:14","pubTimestamp":1723644890,"startTime":"0","endTime":"0","summary":"* NeuroBo Pharmaceuticals Inc    reported a quarterly adjusted loss of $1.85 per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of -16 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NeuroBo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRBO"],"gpt_icon":0},{"id":"2459817828","title":"NeuroBo Pharmaceuticals Q2 EPS $(1.85) Misses $(1.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2459817828","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459817828?lang=en_us&edition=fundamental","pubTime":"2024-08-14 20:15","pubTimestamp":1723637751,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(1.85) per share which missed the analyst consensus estimate of $(1.12) by 65.18 percent. This is a 12233.33 percent decrease over losses of $(0.01) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/08/40364801/neurobo-pharmaceuticals-q2-eps-1-85-misses-1-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NeuroBo Pharmaceuticals Q2 EPS $(1.85) Misses $(1.12) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRBO"],"gpt_icon":0},{"id":"2459642120","title":"NeuroBo Pharmaceuticals: Part 2 of Phase 2a Trial of Da-1241 for Treatment of Mash Underway With Top-Line Data Expected in Q4 of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2459642120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459642120?lang=en_us&edition=fundamental","pubTime":"2024-08-14 20:01","pubTimestamp":1723636864,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240814:nTUA5FTB6Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2459120910","title":"NeuroBo Pharmaceuticals: Joint Research Agreement With Dong-a St & Immunoforge to Develop Long-Acting Once-Monthly Formulation of Da-1726","url":"https://stock-news.laohu8.com/highlight/detail?id=2459120910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459120910?lang=en_us&edition=fundamental","pubTime":"2024-08-14 20:01","pubTimestamp":1723636864,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240814:nTUA5FTB6Y:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JYNT","BK4185","BK4139","NRBO"],"gpt_icon":0},{"id":"2459120686","title":"NeuroBo Pharmaceuticals: Cash at End of Q2 Expected to Fund Co Into Q2 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2459120686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459120686?lang=en_us&edition=fundamental","pubTime":"2024-08-14 20:01","pubTimestamp":1723636864,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240814:nTUA5FTB6Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2459617802","title":"NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2459617802","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459617802?lang=en_us&edition=fundamental","pubTime":"2024-08-14 20:01","pubTimestamp":1723636860,"startTime":"0","endTime":"0","summary":"Successfully Completed a Financing of up to $70 Million, With $20 Million Upfront and an Additional $50 Million of Aggregate Gross Proceeds Upon the Exercise in Full of Clinical Milestone-Based Warrants. $27.9 Million in Cash atEnd of Second Quarter isExpected to Fund the Company Though Multiple Value-Creating Milestones,Into the Second Quarter of 2025. Assuming Positive Results From the DA-1726 Phase 1 MAD Study, the Company Anticipates That the Series A Warrants From the June Financing Could be Exercised in the First Half of 2025, Resulting in Gross Proceeds of $20 Million. In Pre-Clinical Models, DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass and Lipid-Lowering Effects, Plus Superior Glucose Lowering Effects Compared to Survodutide; Lipid-Lowering Effect Also Shown to be Superior Compared to Tirzepatide","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cESxZBhuED.9lDOrhDkOjg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5b3f816329ffcda4530d9c020dc803d5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cESxZBhuED.9lDOrhDkOjg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5b3f816329ffcda4530d9c020dc803d5"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-reports-second-quarter-120100966.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-reports-second-quarter-120100966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4081","BK4202","NRBO","BK4139","OXM","ELP"],"gpt_icon":0},{"id":"2459905514","title":"NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2459905514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459905514?lang=en_us&edition=fundamental","pubTime":"2024-08-13 20:59","pubTimestamp":1723553958,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals (NRBO) has issued an update. NeuroBo Pharmaceuticals, Inc. has successfully completed the enrollment for the first part of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurobo-completes-first-phase-1-enrollment-for-obesity-drug-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurobo-completes-first-phase-1-enrollment-for-obesity-drug-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2459970896","title":"BRIEF-Neurobo Pharmaceuticals Completes Enrollment Of The Sad Part 1 Of Its Phase 1 Clinical Trial Evaluating Da-1726","url":"https://stock-news.laohu8.com/highlight/detail?id=2459970896","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459970896?lang=en_us&edition=fundamental","pubTime":"2024-08-13 20:22","pubTimestamp":1723551727,"startTime":"0","endTime":"0","summary":"Aug 13  - Neurobo Pharmaceuticals Inc   :   * NEUROBO PHARMACEUTICALS COMPLETES ENROLLMENT OF THE SAD PART 1 OF ITS PHASE 1 CLINICAL TRIAL EVALUATING DA-1726 FOR THE TREATMENT OF OBESITY   * TOP LINE DATA FROM SAD PART 1 EXPECTED Q3 2024   * TOP LINE DATA READOUT FROM MAD PART 2 EXPECTED IN Q1 2025Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2459972492","title":"NeuroBo Pharmaceuticals Completes Enrollment of the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2459972492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459972492?lang=en_us&edition=fundamental","pubTime":"2024-08-13 20:01","pubTimestamp":1723550462,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240813:nTUA1CM2LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2459171972","title":"NeuroBo Pharmaceuticals Inc - Top Line Data From Sad Part 1 Expected Q3 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2459171972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459171972?lang=en_us&edition=fundamental","pubTime":"2024-08-13 20:01","pubTimestamp":1723550462,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240813:nTUA1CM2LH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-29","symbol":"NRBO","oldSymbol":"NRBO","defaultRemindTime":1732890600000,"newSymbol":"MTVA","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1732856400000},{"market":"US","date":"2024-11-07","symbol":"NRBO","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-08-14","symbol":"NRBO","fiscalQuarterEnding":"2024/06","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-1.85},{"market":"US","date":"2024-05-09","symbol":"NRBO","fiscalQuarterEnding":"2024/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.32},{"date":"2024-03-28","symbol":"NRBO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711612800000,"name":null,"time":"Pre-Market","dateTimestamp":1711598400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRBO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRBO","date":"2024-11-27","current":-0.730091,"percent":0.930718,"low":-44.328872,"twenty":-4.180567,"median":-1.549047,"eighty":-0.929147,"high":-0.135024,"avg":-3.429469,"sd":4.762423,"marketCap":20247623},"quantilePoints":[{"date":"2020-05-15","current":-10.413512,"twenty":-21.446309,"median":-12.870149,"eighty":-10.951531,"marketCap":221932774},{"date":"2020-05-22","current":-16.924944,"twenty":-21.268861,"median":-12.899701,"eighty":-10.951531,"marketCap":225711052},{"date":"2020-05-29","current":-16.284407,"twenty":-21.045805,"median":-13.069629,"eighty":-10.990071,"marketCap":217168858},{"date":"2020-06-05","current":-16.912626,"twenty":-20.781375,"median":-13.270383,"eighty":-11.055226,"marketCap":225546779},{"date":"2020-06-12","current":-11.985422,"twenty":-20.284273,"median":-13.262358,"eighty":-11.092602,"marketCap":159837593},{"date":"2020-06-19","current":-11.541974,"twenty":-19.824444,"median":-13.143315,"eighty":-11.151201,"marketCap":153923767},{"date":"2020-06-26","current":-11.184752,"twenty":-19.218044,"median":-12.899701,"eighty":-11.185292,"marketCap":149159851},{"date":"2020-07-02","current":-10.568851,"twenty":-18.757024,"median":-12.652199,"eighty":-11.041729,"marketCap":140946203},{"date":"2020-07-10","current":-9.780499,"twenty":-18.514692,"median":-12.397308,"eighty":-10.791204,"marketCap":130432733},{"date":"2020-07-17","current":-10.679713,"twenty":-18.128119,"median":-12.311435,"eighty":-10.607754,"marketCap":142424659},{"date":"2020-07-24","current":-8.868966,"twenty":-17.590116,"median":-12.194829,"eighty":-10.425845,"marketCap":118276534},{"date":"2020-07-31","current":-7.895844,"twenty":-17.479254,"median":-12.126128,"eighty":-10.222472,"marketCap":105298969},{"date":"2020-08-07","current":-8.16684,"twenty":-17.368392,"median":-12.101782,"eighty":-10.052026,"marketCap":108912974},{"date":"2020-08-14","current":-4.485572,"twenty":-17.306787,"median":-12.016217,"eighty":-9.917678,"marketCap":107927337},{"date":"2020-08-21","current":-4.260269,"twenty":-17.162659,"median":-11.954019,"eighty":-9.812526,"marketCap":102506329},{"date":"2020-08-28","current":-4.314888,"twenty":-17.021024,"median":-11.714426,"eighty":-9.536603,"marketCap":103820513},{"date":"2020-09-04","current":-4.171513,"twenty":-16.920017,"median":-11.681479,"eighty":-9.376469,"marketCap":100370781},{"date":"2020-09-11","current":-3.959865,"twenty":-16.873208,"median":-11.62262,"eighty":-8.883748,"marketCap":95278319},{"date":"2020-09-18","current":-4.369507,"twenty":-16.685275,"median":-11.525011,"eighty":-8.35348,"marketCap":105134697},{"date":"2020-09-25","current":-3.925729,"twenty":-16.508259,"median":-11.477217,"eighty":-8.124959,"marketCap":94456954},{"date":"2020-10-02","current":-3.789181,"twenty":-16.272089,"median":-11.285522,"eighty":-7.659338,"marketCap":91171494},{"date":"2020-10-09","current":-4.383161,"twenty":-16.220172,"median":-11.185652,"eighty":-4.433683,"marketCap":105463242},{"date":"2020-10-16","current":-4.485572,"twenty":-16.190382,"median":-11.090871,"eighty":-4.396816,"marketCap":107927337},{"date":"2020-10-23","current":-4.260269,"twenty":-16.095982,"median":-10.953073,"eighty":-4.349024,"marketCap":102506329},{"date":"2020-10-30","current":-3.427332,"twenty":-16.006351,"median":-10.791204,"eighty":-4.317619,"marketCap":82465027},{"date":"2020-11-06","current":-3.50926,"twenty":-15.92851,"median":-10.679713,"eighty":-4.288944,"marketCap":84436303},{"date":"2020-11-13","current":-3.677857,"twenty":-15.831305,"median":-10.575969,"eighty":-4.263,"marketCap":86407578},{"date":"2020-11-20","current":-3.747778,"twenty":-15.388459,"median":-10.444344,"eighty":-4.189264,"marketCap":88050308},{"date":"2020-11-27","current":-3.789731,"twenty":-15.151151,"median":-10.259352,"eighty":-4.171513,"marketCap":89035946},{"date":"2020-12-04","current":-3.810708,"twenty":-15.083402,"median":-10.222888,"eighty":-4.123722,"marketCap":89528765},{"date":"2020-12-11","current":-3.803716,"twenty":-14.406883,"median":-10.143732,"eighty":-3.987175,"marketCap":89364492},{"date":"2020-12-18","current":-4.265196,"twenty":-13.978371,"median":-10.015923,"eighty":-3.987175,"marketCap":100206508},{"date":"2020-12-24","current":-4.258204,"twenty":-13.74195,"median":-9.936576,"eighty":-3.997031,"marketCap":100042234},{"date":"2020-12-31","current":-3.670865,"twenty":-13.658642,"median":-9.89752,"eighty":-3.987175,"marketCap":86243305},{"date":"2021-01-08","current":-5.23303,"twenty":-13.524857,"median":-9.842089,"eighty":-3.987175,"marketCap":122944810},{"date":"2021-01-15","current":-5.048827,"twenty":-13.446425,"median":-9.688481,"eighty":-3.987175,"marketCap":118617152},{"date":"2021-01-22","current":-4.841154,"twenty":-13.446425,"median":-9.540298,"eighty":-3.987175,"marketCap":113738061},{"date":"2021-01-29","current":-4.831717,"twenty":-13.38732,"median":-9.472549,"eighty":-3.992103,"marketCap":113516349},{"date":"2021-02-05","current":-4.94496,"twenty":-13.28735,"median":-9.244665,"eighty":-4.010682,"marketCap":116176889},{"date":"2021-02-12","current":-5.199758,"twenty":-13.263963,"median":-8.868966,"eighty":-4.033057,"marketCap":122163103},{"date":"2021-02-19","current":-5.086514,"twenty":-13.236601,"median":-8.647242,"eighty":-4.044248,"marketCap":119502563},{"date":"2021-02-26","current":-4.029576,"twenty":-13.161203,"median":-8.253066,"eighty":-4.044248,"marketCap":94670862},{"date":"2021-03-05","current":-3.70872,"twenty":-13.109369,"median":-8.154522,"eighty":-4.03195,"marketCap":87132666},{"date":"2021-03-12","current":-4.180567,"twenty":-12.964717,"median":-8.086773,"eighty":-4.03195,"marketCap":98218247},{"date":"2021-03-19","current":-4.491987,"twenty":-12.917433,"median":-7.600211,"eighty":-4.044248,"marketCap":105534731},{"date":"2021-03-26","current":-4.246626,"twenty":-12.840596,"median":-5.523809,"eighty":-4.058179,"marketCap":99770229},{"date":"2021-04-01","current":-4.369306,"twenty":-12.722386,"median":-5.374341,"eighty":-4.055448,"marketCap":102652480},{"date":"2021-04-09","current":-3.699283,"twenty":-12.582012,"median":-5.341312,"eighty":-4.027463,"marketCap":86910955},{"date":"2021-04-16","current":-2.412995,"twenty":-12.545071,"median":-5.225831,"eighty":-3.987175,"marketCap":71612853},{"date":"2021-04-23","current":-2.666994,"twenty":-12.397308,"median":-5.17442,"eighty":-3.980347,"marketCap":79151048},{"date":"2021-04-30","current":-2.681935,"twenty":-12.352979,"median":-5.102759,"eighty":-3.925729,"marketCap":79594471},{"date":"2021-05-07","current":-2.203819,"twenty":-12.338203,"median":-5.086514,"eighty":-3.891592,"marketCap":65404928},{"date":"2021-05-14","current":-2.151525,"twenty":-12.284668,"median":-5.048796,"eighty":-3.850274,"marketCap":63852946},{"date":"2021-05-21","current":-2.219312,"twenty":-12.231783,"median":-4.956726,"eighty":-3.824692,"marketCap":62744388},{"date":"2021-05-28","current":-2.21147,"twenty":-12.194829,"median":-4.929911,"eighty":-3.810708,"marketCap":62522676},{"date":"2021-06-04","current":-2.407522,"twenty":-12.145557,"median":-4.88362,"eighty":-3.803038,"marketCap":68065467},{"date":"2021-06-11","current":-2.438891,"twenty":-12.131716,"median":-4.831717,"eighty":-3.789621,"marketCap":68952314},{"date":"2021-06-18","current":-2.577584,"twenty":-12.123004,"median":-4.60523,"eighty":-3.775747,"marketCap":72873461},{"date":"2021-06-25","current":-2.561819,"twenty":-12.10561,"median":-4.499226,"eighty":-3.747516,"marketCap":72427752},{"date":"2021-07-02","current":-2.364756,"twenty":-12.101782,"median":-4.485572,"eighty":-3.706833,"marketCap":66856386},{"date":"2021-07-09","current":-2.412051,"twenty":-12.091092,"median":-4.479342,"eighty":-3.67506,"marketCap":68193513},{"date":"2021-07-16","current":-2.151928,"twenty":-12.061794,"median":-4.460975,"eighty":-3.623959,"marketCap":60839311},{"date":"2021-07-23","current":-2.419934,"twenty":-12.010058,"median":-4.429745,"eighty":-3.585726,"marketCap":68416369},{"date":"2021-07-30","current":-2.593349,"twenty":-11.984312,"median":-4.416491,"eighty":-3.548292,"marketCap":73319170},{"date":"2021-08-06","current":-2.916533,"twenty":-11.96584,"median":-4.380952,"eighty":-3.4642,"marketCap":82456210},{"date":"2021-08-13","current":-2.790412,"twenty":-11.832436,"median":-4.369306,"eighty":-3.015852,"marketCap":78890536},{"date":"2021-08-20","current":-2.474584,"twenty":-11.736598,"median":-4.347266,"eighty":-2.87712,"marketCap":73764879},{"date":"2021-08-27","current":-2.953054,"twenty":-11.711962,"median":-4.33537,"eighty":-2.827018,"marketCap":88027575},{"date":"2021-09-03","current":-3.125004,"twenty":-11.692518,"median":-4.31801,"eighty":-2.848448,"marketCap":93153232},{"date":"2021-09-10","current":-3.117527,"twenty":-11.684267,"median":-4.303978,"eighty":-2.853472,"marketCap":92930377},{"date":"2021-09-17","current":-3.177336,"twenty":-11.664521,"median":-4.294406,"eighty":-2.866391,"marketCap":94713214},{"date":"2021-09-24","current":-2.855865,"twenty":-11.632499,"median":-4.290694,"eighty":-2.867827,"marketCap":85130465},{"date":"2021-10-01","current":-1.869021,"twenty":-11.601457,"median":-4.284374,"eighty":-2.831941,"marketCap":55713655},{"date":"2021-10-08","current":-1.73071,"twenty":-11.558617,"median":-4.273924,"eighty":-2.784827,"marketCap":51590743},{"date":"2021-10-15","current":-1.695026,"twenty":-11.528404,"median":-4.265196,"eighty":-2.74889,"marketCap":50527016},{"date":"2021-10-22","current":-1.65042,"twenty":-11.503211,"median":-4.259237,"eighty":-2.699171,"marketCap":49197357},{"date":"2021-10-29","current":-1.57905,"twenty":-11.488459,"median":-4.246626,"eighty":-2.678637,"marketCap":47069904},{"date":"2021-11-05","current":-1.784148,"twenty":-11.449468,"median":-4.213596,"eighty":-2.659523,"marketCap":53183672},{"date":"2021-11-12","current":-1.614735,"twenty":-11.383983,"median":-4.185168,"eighty":-2.638271,"marketCap":48133631},{"date":"2021-11-19","current":-1.399362,"twenty":-11.298056,"median":-4.182868,"eighty":-2.592712,"marketCap":42283134},{"date":"2021-11-26","current":-1.566582,"twenty":-11.219846,"median":-4.17604,"eighty":-2.563396,"marketCap":47335836},{"date":"2021-12-03","current":-1.214541,"twenty":-11.203383,"median":-4.152256,"eighty":-2.523983,"marketCap":36698569},{"date":"2021-12-10","current":-1.223342,"twenty":-11.185472,"median":-4.14868,"eighty":-2.484509,"marketCap":36964500},{"date":"2021-12-17","current":-1.249745,"twenty":-11.167707,"median":-4.123722,"eighty":-2.442982,"marketCap":37762296},{"date":"2021-12-23","current":-1.333355,"twenty":-11.099525,"median":-4.105072,"eighty":-2.419934,"marketCap":40288646},{"date":"2021-12-31","current":-1.073725,"twenty":-11.082218,"median":-4.062276,"eighty":-2.407522,"marketCap":32443662},{"date":"2022-01-07","current":-1.311352,"twenty":-11.014737,"median":-4.029576,"eighty":-2.388404,"marketCap":39623817},{"date":"2022-01-14","current":-1.152934,"twenty":-10.953073,"median":-4.009817,"eighty":-2.364756,"marketCap":34837047},{"date":"2022-01-21","current":-0.985714,"twenty":-10.946907,"median":-3.989502,"eighty":-2.339532,"marketCap":29784346},{"date":"2022-01-28","current":-0.888903,"twenty":-10.822036,"median":-3.987175,"eighty":-2.312649,"marketCap":26859097},{"date":"2022-02-04","current":-0.851323,"twenty":-10.791204,"median":-3.97352,"eighty":-2.264796,"marketCap":25723570},{"date":"2022-02-11","current":-0.787867,"twenty":-10.716668,"median":-3.946211,"eighty":-2.222159,"marketCap":23806201},{"date":"2022-02-18","current":-0.744742,"twenty":-10.683377,"median":-3.896516,"eighty":-2.209795,"marketCap":22503137},{"date":"2022-02-25","current":-0.682519,"twenty":-10.658736,"median":-3.891592,"eighty":-2.192986,"marketCap":20623000},{"date":"2022-03-04","current":-0.677679,"twenty":-10.607754,"median":-3.873637,"eighty":-2.151767,"marketCap":20476738},{"date":"2022-03-11","current":-0.665181,"twenty":-10.574546,"median":-3.847037,"eighty":-2.026673,"marketCap":20099114},{"date":"2022-03-18","current":-0.739286,"twenty":-10.525868,"median":-3.831684,"eighty":-1.810109,"marketCap":22338259},{"date":"2022-03-25","current":-0.8581,"twenty":-10.465491,"median":-3.824005,"eighty":-1.748553,"marketCap":25928337},{"date":"2022-04-01","current":-1.569805,"twenty":-10.425845,"median":-3.810708,"eighty":-1.718221,"marketCap":23992904},{"date":"2022-04-08","current":-1.526369,"twenty":-10.321016,"median":-3.803402,"eighty":-1.691457,"marketCap":23329028},{"date":"2022-04-14","current":-1.516426,"twenty":-10.250117,"median":-3.796284,"eighty":-1.67183,"marketCap":23177056},{"date":"2022-04-22","current":-1.382716,"twenty":-10.231744,"median":-3.789731,"eighty":-1.645067,"marketCap":21133432},{"date":"2022-04-29","current":-1.121663,"twenty":-10.223303,"median":-3.782739,"eighty":-1.605814,"marketCap":17143502},{"date":"2022-05-06","current":-1.064097,"twenty":-10.217139,"median":-3.775747,"eighty":-1.575806,"marketCap":16263665},{"date":"2022-05-13","current":-0.915144,"twenty":-10.18447,"median":-3.754771,"eighty":-1.569701,"marketCap":13576161},{"date":"2022-05-20","current":-0.910651,"twenty":-10.12215,"median":-3.740786,"eighty":-1.550024,"marketCap":13509506},{"date":"2022-05-27","current":-0.774961,"twenty":-10.064609,"median":-3.704001,"eighty":-1.524171,"marketCap":11496544},{"date":"2022-06-03","current":-0.799403,"twenty":-10.022485,"median":-3.685728,"eighty":-1.51517,"marketCap":11859144},{"date":"2022-06-10","current":-0.834629,"twenty":-9.994581,"median":-3.649889,"eighty":-1.425765,"marketCap":12381714},{"date":"2022-06-17","current":-0.759505,"twenty":-9.946401,"median":-3.621911,"eighty":-1.386045,"marketCap":11267253},{"date":"2022-06-24","current":-0.816836,"twenty":-9.9202,"median":-3.602976,"eighty":-1.355357,"marketCap":12117763},{"date":"2022-07-01","current":-0.844693,"twenty":-9.915997,"median":-3.577533,"eighty":-1.336227,"marketCap":12531020},{"date":"2022-07-08","current":-0.993862,"twenty":-9.886434,"median":-3.567166,"eighty":-1.318393,"marketCap":14743945},{"date":"2022-07-15","current":-1.006622,"twenty":-9.868804,"median":-3.539017,"eighty":-1.274388,"marketCap":14933243},{"date":"2022-07-22","current":-0.886029,"twenty":-9.84692,"median":-3.488778,"eighty":-1.248132,"marketCap":13144240},{"date":"2022-07-29","current":-0.757348,"twenty":-9.802671,"median":-3.289477,"eighty":-1.230383,"marketCap":11235259},{"date":"2022-08-05","current":-0.670363,"twenty":-9.782963,"median":-3.147432,"eighty":-1.214541,"marketCap":9944831},{"date":"2022-08-12","current":-0.748449,"twenty":-9.633271,"median":-3.121265,"eighty":-1.156454,"marketCap":10640702},{"date":"2022-08-19","current":-0.714881,"twenty":-9.566313,"median":-3.095099,"eighty":-1.116046,"marketCap":10163457},{"date":"2022-08-26","current":-0.749762,"twenty":-9.529212,"median":-3.039029,"eighty":-1.080766,"marketCap":10659365},{"date":"2022-09-02","current":-0.57348,"twenty":-9.513502,"median":-2.99791,"eighty":-1.068283,"marketCap":8153161},{"date":"2022-09-09","current":-0.517782,"twenty":-9.488098,"median":-2.975482,"eighty":-1.053095,"marketCap":7361308},{"date":"2022-09-16","current":-1.120204,"twenty":-9.450377,"median":-2.938101,"eighty":-1.052339,"marketCap":15925934},{"date":"2022-09-23","current":-0.971426,"twenty":-9.376469,"median":-2.916533,"eighty":-1.039248,"marketCap":13810770},{"date":"2022-09-30","current":-0.85578,"twenty":-9.226188,"median":-2.904686,"eighty":-1.015533,"marketCap":12166631},{"date":"2022-10-07","current":-0.724507,"twenty":-9.026636,"median":-2.885769,"eighty":-1.006334,"marketCap":10300311},{"date":"2022-10-14","current":-0.79702,"twenty":-8.898529,"median":-2.853472,"eighty":-0.987368,"marketCap":11331231},{"date":"2022-10-21","current":-0.63449,"twenty":-8.735932,"median":-2.82596,"eighty":-0.976302,"marketCap":9020548},{"date":"2022-10-28","current":-0.522595,"twenty":-8.647242,"median":-2.796972,"eighty":-0.950584,"marketCap":7429732},{"date":"2022-11-04","current":-0.163155,"twenty":-8.534598,"median":-2.774647,"eighty":-0.9206,"marketCap":2319569},{"date":"2022-11-11","current":-0.388894,"twenty":-8.379985,"median":-2.750182,"eighty":-0.912859,"marketCap":5528903},{"date":"2022-11-18","current":-0.614292,"twenty":-8.238284,"median":-2.726759,"eighty":-0.903419,"marketCap":8519621},{"date":"2022-11-25","current":-0.717456,"twenty":-8.174231,"median":-2.689406,"eighty":-0.897994,"marketCap":9950397},{"date":"2022-12-02","current":-0.736213,"twenty":-8.161913,"median":-2.681935,"eighty":-0.880637,"marketCap":10210538},{"date":"2022-12-09","current":-0.829998,"twenty":-8.13974,"median":-2.666994,"eighty":-0.863898,"marketCap":11511244},{"date":"2022-12-16","current":-0.679942,"twenty":-8.107714,"median":-2.659523,"eighty":-0.851834,"marketCap":9430115},{"date":"2022-12-23","current":-1.112413,"twenty":-8.088005,"median":-2.65401,"eighty":-0.849185,"marketCap":15428051},{"date":"2022-12-30","current":-0.9815,"twenty":-8.04366,"median":-2.632762,"eighty":-0.849613,"marketCap":13612428},{"date":"2023-01-06","current":-0.967,"twenty":-7.895844,"median":-2.624879,"eighty":-0.851323,"marketCap":13411325},{"date":"2023-01-13","current":-1.053044,"twenty":-7.600211,"median":-2.584936,"eighty":-0.852601,"marketCap":14604665},{"date":"2023-01-20","current":-1.114875,"twenty":-6.389506,"median":-2.56576,"eighty":-0.855144,"marketCap":15462201},{"date":"2023-01-27","current":-1.107625,"twenty":-5.691816,"median":-2.546054,"eighty":-0.857636,"marketCap":15361649},{"date":"2023-02-03","current":-1.110771,"twenty":-5.482257,"median":-2.515938,"eighty":-0.861465,"marketCap":15405285},{"date":"2023-02-10","current":-0.992444,"twenty":-5.409257,"median":-2.501627,"eighty":-0.865489,"marketCap":13764204},{"date":"2023-02-17","current":-0.971241,"twenty":-5.360186,"median":-2.468501,"eighty":-0.869571,"marketCap":13470138},{"date":"2023-02-24","current":-0.783148,"twenty":-5.345087,"median":-2.449118,"eighty":-0.864693,"marketCap":10861484},{"date":"2023-03-03","current":-1.04511,"twenty":-5.341312,"median":-2.431048,"eighty":-0.86875,"marketCap":14494627},{"date":"2023-03-10","current":-0.989434,"twenty":-5.296014,"median":-2.413885,"eighty":-0.873366,"marketCap":13722466},{"date":"2023-03-17","current":-0.943882,"twenty":-5.246144,"median":-2.407522,"eighty":-0.87543,"marketCap":13090697},{"date":"2023-03-24","current":-0.889164,"twenty":-5.224391,"median":-2.390121,"eighty":-0.875485,"marketCap":12331816},{"date":"2023-03-31","current":-0.964834,"twenty":-5.207307,"median":-2.383996,"eighty":-0.875557,"marketCap":13475830},{"date":"2023-04-06","current":-1.40096,"twenty":-5.189623,"median":-2.364756,"eighty":-0.877618,"marketCap":19567213},{"date":"2023-04-14","current":-1.413997,"twenty":-5.150582,"median":-2.341109,"eighty":-0.880637,"marketCap":19749296},{"date":"2023-04-21","current":-1.342587,"twenty":-5.114825,"median":-2.333226,"eighty":-0.882794,"marketCap":18751912},{"date":"2023-04-28","current":-1.314373,"twenty":-5.105172,"median":-2.315439,"eighty":-0.887179,"marketCap":18357850},{"date":"2023-05-05","current":-1.167467,"twenty":-5.089021,"median":-2.289891,"eighty":-0.889007,"marketCap":16306011},{"date":"2023-05-12","current":-1.126606,"twenty":-5.086514,"median":-2.262443,"eighty":-0.89258,"marketCap":15735300},{"date":"2023-05-19","current":-1.197909,"twenty":-5.082739,"median":-2.234996,"eighty":-0.897994,"marketCap":16406564},{"date":"2023-05-26","current":-1.131357,"twenty":-5.065777,"median":-2.219312,"eighty":-0.898502,"marketCap":15495070},{"date":"2023-06-02","current":-1.093765,"twenty":-5.048815,"median":-2.211379,"eighty":-0.898646,"marketCap":14980202},{"date":"2023-06-09","current":-0.990534,"twenty":-5.038731,"median":-2.203819,"eighty":-0.8996,"marketCap":13566359},{"date":"2023-06-16","current":-0.982379,"twenty":-4.990217,"median":-2.177205,"eighty":-0.903576,"marketCap":13454668},{"date":"2023-06-23","current":-0.778305,"twenty":-4.956726,"median":-2.155869,"eighty":-0.89861,"marketCap":10659671},{"date":"2023-06-30","current":-0.870596,"twenty":-4.954863,"median":-2.150129,"eighty":-0.889112,"marketCap":11923685},{"date":"2023-07-07","current":-0.872784,"twenty":-4.948735,"median":-2.091835,"eighty":-0.883872,"marketCap":11953651},{"date":"2023-07-14","current":-0.891083,"twenty":-4.926901,"median":-1.873449,"eighty":-0.879326,"marketCap":12204274},{"date":"2023-07-21","current":-0.970246,"twenty":-4.910272,"median":-1.842242,"eighty":-0.876657,"marketCap":13288493},{"date":"2023-07-28","current":-0.998292,"twenty":-4.878901,"median":-1.793159,"eighty":-0.879326,"marketCap":13672601},{"date":"2023-08-04","current":-1.026337,"twenty":-4.848703,"median":-1.756601,"eighty":-0.880637,"marketCap":14056709},{"date":"2023-08-11","current":-1.467726,"twenty":-4.835492,"median":-1.73071,"eighty":-0.883872,"marketCap":16331390},{"date":"2023-08-18","current":-1.999685,"twenty":-4.775095,"median":-1.756601,"eighty":-0.887753,"marketCap":22250498},{"date":"2023-08-25","current":-1.814913,"twenty":-4.669401,"median":-1.793159,"eighty":-0.88906,"marketCap":20194536},{"date":"2023-09-01","current":-1.537236,"twenty":-4.601455,"median":-1.763361,"eighty":-0.890315,"marketCap":17104830},{"date":"2023-09-08","current":-1.581789,"twenty":-4.551504,"median":-1.748553,"eighty":-0.892595,"marketCap":17600566},{"date":"2023-09-15","current":-1.56901,"twenty":-4.499226,"median":-1.740659,"eighty":-0.894862,"marketCap":17458378},{"date":"2023-09-20","current":-1.827001,"twenty":-4.499226,"median":-1.744606,"eighty":-0.89543,"marketCap":20329038},{"date":"2023-09-29","current":-1.642919,"twenty":-4.499226,"median":-1.735685,"eighty":-0.896567,"marketCap":18280763},{"date":"2023-10-05","current":-1.55416,"twenty":-4.497778,"median":-1.73071,"eighty":-0.897849,"marketCap":17293133},{"date":"2023-10-13","current":-1.61978,"twenty":-4.493435,"median":-1.724317,"eighty":-0.898285,"marketCap":18023287},{"date":"2023-10-20","current":-1.5027,"twenty":-4.488138,"median":-1.712868,"eighty":-0.898538,"marketCap":16720538},{"date":"2023-10-27","current":-1.516169,"twenty":-4.485572,"median":-1.708408,"eighty":-0.89861,"marketCap":16870412},{"date":"2023-11-03","current":-1.429136,"twenty":-4.485572,"median":-1.692307,"eighty":-0.898789,"marketCap":15901996},{"date":"2023-11-10","current":-1.505808,"twenty":-4.485572,"median":-1.686104,"eighty":-0.899039,"marketCap":16755124},{"date":"2023-11-17","current":-1.390102,"twenty":-4.473113,"median":-1.668262,"eighty":-0.902844,"marketCap":16447691},{"date":"2023-11-24","current":-1.410529,"twenty":-4.472156,"median":-1.659341,"eighty":-0.905773,"marketCap":16689382},{"date":"2023-12-01","current":-1.469575,"twenty":-4.463163,"median":-1.644992,"eighty":-0.909822,"marketCap":17388008},{"date":"2023-12-08","current":-1.669673,"twenty":-4.448037,"median":-1.642919,"eighty":-0.911082,"marketCap":19755571},{"date":"2023-12-15","current":-1.637854,"twenty":-4.437252,"median":-1.642208,"eighty":-0.912371,"marketCap":19379090},{"date":"2023-12-22","current":-1.433081,"twenty":-4.426373,"median":-1.640806,"eighty":-0.912923,"marketCap":16956216},{"date":"2023-12-29","current":-1.640396,"twenty":-4.421071,"median":-1.639945,"eighty":-0.913773,"marketCap":19409166},{"date":"2024-01-05","current":-1.656552,"twenty":-4.416491,"median":-1.640806,"eighty":-0.914951,"marketCap":19600318},{"date":"2024-01-12","current":-1.320321,"twenty":-4.416491,"median":-1.638674,"eighty":-0.915144,"marketCap":15622036},{"date":"2024-01-19","current":-1.406429,"twenty":-4.395289,"median":-1.623233,"eighty":-0.915274,"marketCap":16640864},{"date":"2024-01-26","current":-1.279276,"twenty":-4.384527,"median":-1.614996,"eighty":-0.915306,"marketCap":15136394},{"date":"2024-02-02","current":-2.242905,"twenty":-4.379627,"median":-1.614321,"eighty":-0.91628,"marketCap":26538055},{"date":"2024-02-09","current":-1.775462,"twenty":-4.371354,"median":-1.61978,"eighty":-0.916523,"marketCap":21007272},{"date":"2024-02-16","current":-1.980481,"twenty":-4.369346,"median":-1.630543,"eighty":-0.916961,"marketCap":23433054},{"date":"2024-02-23","current":-2.351155,"twenty":-4.357137,"median":-1.639945,"eighty":-0.920764,"marketCap":27818867},{"date":"2024-03-01","current":-2.374117,"twenty":-4.349024,"median":-1.641498,"eighty":-0.92339,"marketCap":28090555},{"date":"2024-03-08","current":-2.238805,"twenty":-4.346914,"median":-1.646559,"eighty":-0.923878,"marketCap":26489539},{"date":"2024-03-15","current":-1.865671,"twenty":-4.339425,"median":-1.65524,"eighty":-0.927855,"marketCap":22074616},{"date":"2024-03-22","current":-1.877972,"twenty":-4.33537,"median":-1.659341,"eighty":-0.934853,"marketCap":22220163},{"date":"2024-03-28","current":-1.779563,"twenty":-4.332639,"median":-1.668967,"eighty":-0.938409,"marketCap":21055787},{"date":"2024-04-05","current":-1.53043,"twenty":-4.325578,"median":-1.659341,"eighty":-0.94022,"marketCap":19084464},{"date":"2024-04-12","current":-1.408468,"twenty":-4.318635,"median":-1.65283,"eighty":-0.942578,"marketCap":17563594},{"date":"2024-04-19","current":-1.353388,"twenty":-4.314007,"median":-1.646055,"eighty":-0.943882,"marketCap":16876750},{"date":"2024-04-26","current":-1.203886,"twenty":-4.305719,"median":-1.641152,"eighty":-0.945398,"marketCap":15012457},{"date":"2024-05-03","current":-1.467473,"twenty":-4.294925,"median":-1.639494,"eighty":-0.948399,"marketCap":18299387},{"date":"2024-05-10","current":-1.57173,"twenty":-4.294406,"median":-1.623233,"eighty":-0.949983,"marketCap":19599477},{"date":"2024-05-17","current":-1.361134,"twenty":-4.294406,"median":-1.614996,"eighty":-0.951444,"marketCap":22567609},{"date":"2024-05-24","current":-1.176198,"twenty":-4.294168,"median":-1.612248,"eighty":-0.953408,"marketCap":19501357},{"date":"2024-05-31","current":-1.201349,"twenty":-4.292564,"median":-1.608231,"eighty":-0.955298,"marketCap":19918368},{"date":"2024-06-07","current":-1.192472,"twenty":-4.287297,"median":-1.605814,"eighty":-0.95801,"marketCap":19771188},{"date":"2024-06-14","current":-1.159923,"twenty":-4.286172,"median":-1.602511,"eighty":-0.959808,"marketCap":19231527},{"date":"2024-06-21","current":-1.213185,"twenty":-4.284734,"median":-1.597313,"eighty":-0.960362,"marketCap":20114608},{"date":"2024-06-28","current":-2.893625,"twenty":-4.282487,"median":-1.597313,"eighty":-0.9605,"marketCap":47976297},{"date":"2024-07-05","current":-2.694809,"twenty":-4.274937,"median":-1.602511,"eighty":-0.9605,"marketCap":44679926},{"date":"2024-07-12","current":-2.308609,"twenty":-4.273924,"median":-1.605889,"eighty":-0.964834,"marketCap":38276732},{"date":"2024-07-15","current":-2.477048,"twenty":-4.273924,"median":-1.605965,"eighty":-0.964834,"marketCap":41069455},{"date":"2024-08-02","current":-1.874278,"twenty":-4.273924,"median":-1.606656,"eighty":-0.964834,"marketCap":31075523},{"date":"2024-08-09","current":-1.938778,"twenty":-4.273924,"median":-1.610587,"eighty":-0.9657,"marketCap":32144944},{"date":"2024-08-16","current":-1.27386,"twenty":-4.270433,"median":-1.614321,"eighty":-0.96727,"marketCap":32991710},{"date":"2024-08-23","current":-1.196062,"twenty":-4.263225,"median":-1.609115,"eighty":-0.967988,"marketCap":30976805},{"date":"2024-08-30","current":-1.150185,"twenty":-4.260269,"median":-1.605889,"eighty":-0.969172,"marketCap":29788653},{"date":"2024-09-06","current":-1.100147,"twenty":-4.259856,"median":-1.604163,"eighty":-0.970332,"marketCap":28492720},{"date":"2024-09-13","current":-1.196062,"twenty":-4.256805,"median":-1.597313,"eighty":-0.970791,"marketCap":30976805},{"date":"2024-09-20","current":-1.068263,"twenty":-4.250294,"median":-1.590533,"eighty":-0.971241,"marketCap":27666954},{"date":"2024-09-27","current":-1.078094,"twenty":-4.243893,"median":-1.581789,"eighty":-0.971241,"marketCap":27921558},{"date":"2024-10-04","current":-0.868374,"twenty":-4.23003,"median":-1.574094,"eighty":-0.970791,"marketCap":22490009},{"date":"2024-10-11","current":-0.80939,"twenty":-4.216428,"median":-1.571428,"eighty":-0.967135,"marketCap":20962386},{"date":"2024-10-18","current":-1.035495,"twenty":-4.208232,"median":-1.569805,"eighty":-0.964834,"marketCap":26818275},{"date":"2024-10-25","current":-0.917527,"twenty":-4.201554,"median":-1.56901,"eighty":-0.960201,"marketCap":23763028},{"date":"2024-10-31","current":-0.868374,"twenty":-4.185168,"median":-1.563139,"eighty":-0.956849,"marketCap":22490009},{"date":"2024-11-08","current":-0.820128,"twenty":-4.185168,"median":-1.557786,"eighty":-0.94949,"marketCap":22744613},{"date":"2024-11-15","current":-0.742518,"twenty":-4.185168,"median":-1.55416,"eighty":-0.943742,"marketCap":20592263},{"date":"2024-11-22","current":-0.730091,"twenty":-4.180567,"median":-1.551511,"eighty":-0.937188,"marketCap":20247623},{"date":"2024-11-27","current":-0.730091,"twenty":-4.180567,"median":-1.549047,"eighty":-0.929147,"marketCap":20247623}],"updateTime":1746941472885}}}